WANBURY
Back to Balance Sheet
|
WANBURY Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹65 Cr | ₹60 Cr | ₹1,072 Cr | ₹934 Cr | ₹889 Cr |
What is the latest Contingent Liabilities ratio of WANBURY ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹65 Cr |
| Mar2024 | ₹60 Cr |
| Mar2023 | ₹1,072 Cr |
| Mar2022 | ₹934 Cr |
| Mar2021 | ₹889 Cr |
How is Contingent Liabilities of WANBURY Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹65 Cr | 9.00 | |
| Mar2024 | ₹60 Cr | -94.43 | |
| Mar2023 | ₹1,072 Cr | 14.78 | |
| Mar2022 | ₹934 Cr | 5.01 | |
| Mar2021 | ₹889 Cr | - | |
Compare Contingent Liabilities of peers of WANBURY
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| WANBURY | ₹1,005.8 Cr | 2.8% | 8.3% | 1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹447,704.0 Cr | -0.5% | 3.9% | 12.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹173,684.0 Cr | -3.1% | -0.1% | 0.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹157,093.0 Cr | 3.1% | 6.7% | 45.5% | Stock Analytics | |
| CIPLA | ₹117,699.0 Cr | 1.4% | 4.8% | -2.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹111,792.0 Cr | 0.8% | 3.9% | 1.5% | Stock Analytics | |
WANBURY Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| WANBURY | 2.8% |
8.3% |
1% |
| SENSEX | 1% |
2.9% |
-6.1% |
You may also like the below Video Courses